1y return+30.3%S&P 500 +20.9%
3y return+55.4%S&P 500 +68.5%
These returns are for its stock picks as disclosed on Form 13F: last quarter's holdings, valued at this quarter's prices. They miss trades within each quarter, short positions, options, bonds, cash and fees, so they aren't the returns its clients got.
$100 invested in its stock picks
Since December 31, 2022: $166 against $195 in the S&P 500.2
Artia Global Partners LPS&P 500 (SPY)
Top holdings
At the end of June 30, 2026. Change is in shares since the quarter before.2
| Stock | Value | Share of portfolio | Change |
|---|---|---|---|
| ABVXAbivax Sa | $68.8M | 13.1% | −14.0% |
| INSMInsmed Inc | $62.8M | 11.9% | −6.3% |
| TRVITrevi Therapeutics Inc | $41.2M | 7.8% | +9.8% |
| BTSGBrightspring Health Svcs Inc | $36.1M | 6.9% | +861.6% |
| RVMDRevolution Medicines Inc | $34.7M | 6.6% | +48.3% |
| ARGXArgenx Se | $27.6M | 5.2% | |
| Alkermes PLCCUSIP G01767105 | $23.5M | 4.5% | New |
| TVTXTravere Therapeutics Inc | $19.3M | 3.7% | +379.5% |
| Astrazeneca PLCCUSIP G0593M107 | $18.7M | 3.5% | +3.1% |
| Newamsterdam Pharma CompanyCUSIP N62509109 | $17.1M | 3.2% | |
| DNTHDianthus Therapeutics Inc | $15.9M | 3.0% | |
| DGXQuest Diagnostics Inc | $13.8M | 2.6% | +59.5% |
| IONSIonis Pharmaceuticals Inc | $11.4M | 2.2% | |
| EYPTEyepoint Inc | $11.0M | 2.1% | |
| ALMSAlumis Inc | $7.8M | 1.5% | −14.3% |
| VKTXViking Therapeutics Inc | $7.1M | 1.3% | |
| CELCCelcuity Inc | $6.2M | 1.2% | +280.8% |
| CYTKCytokinetics Inc | $6.0M | 1.1% | +333.7% |
| MRKMerck & Co Inc | $6.0M | 1.1% | |
| RAPPRapport Therapeutics Inc | $5.8M | 1.1% | |
| JNJJohnson & Johnson | $5.7M | 1.1% | |
| GHGuardant Health Inc | $5.7M | 1.1% | New |
| ABSIAbsci Corporation | $5.4M | 1.0% | New |
| SRRKScholar Rock Hldg Corp | $5.3M | 1.0% | |
| SIONSionna Therapeutics Inc | $5.3M | 1.0% |
Best picks still held
How each current holding has done since the quarter it first appeared in its filings (up to six years back).
| Stock | Held since | Return since | Now worth |
|---|---|---|---|
| PTGXProtagonist Therapeutics Inc | June 30, 2023 | +343.8% | $2.8M |
| RVMDRevolution Medicines Inc | September 30, 2024 | +313.0% | $34.7M |
| INSMInsmed Inc | December 31, 2023 | +244.0% | $62.8M |
| TRVITrevi Therapeutics Inc | June 30, 2025 | +241.0% | $41.2M |
| TVTXTravere Therapeutics Inc | March 31, 2025 | +217.0% | $19.3M |
| DNTHDianthus Therapeutics Inc | September 30, 2025 | +147.7% | $15.9M |
| ARGXArgenx Se | December 31, 2022 | +144.9% | $27.6M |
| BTSGBrightspring Health Svcs Inc | September 30, 2025 | +135.9% | $36.1M |
| Kiniksa Pharmaceuticals IntlCUSIP G52694109 | June 30, 2025 | +131.1% | $1.9M |
| MLYSMineralys Therapeutics Inc | June 30, 2025 | +99.4% | $3.7M |
Sold off last quarter
- LLYEli Lilly & Co was $35.2M
- Terns Pharmaceuticals IncCUSIP 880881107 was $5.5M
- Ascendis Pharma A/sCUSIP 04351P101 was $4.1M
- ABBVAbbvie Inc was $3.2M
- Soleno Therapeutics IncCUSIP 834203309 was $2.3M
- BBIOBridgebio Pharma Inc was $1.5M
- Apogee Therapeutics IncCUSIP 03770N101 was $495K
- AVTXAvalo Therapeutics Inc was $433K
Quarter by quarter
| Quarter | Its picks | S&P 500 |
|---|---|---|
| June 30, 2026 | +8.8% | +14.8% |
| March 31, 2026 | −7.7% | −4.6% |
| December 31, 2025 | +8.1% | +2.4% |
| September 30, 2025 | +20.0% | +7.8% |
| June 30, 2025 | +11.3% | +10.5% |
| March 31, 2025 | +3.2% | −4.6% |
| December 31, 2024 | −16.2% | +2.1% |
| September 30, 2024 | −1.7% | +5.4% |
| June 30, 2024 | +1.3% | +4.0% |
| March 31, 2024 | +19.6% | +10.0% |
| December 31, 2023 | +5.2% | +11.2% |
| September 30, 2023 | −1.0% | −3.6% |
| June 30, 2023 | +4.8% | +8.3% |
| March 31, 2023 | +1.9% | +7.0% |
Sources
Every number on this page points here. Each one links to the public record.
- 1SEC EDGAR: Artia Global Partners LP Form 13F filingshttps://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1937964&type=13F-HR&dateb=&owner=include&count=40CIK 1937964
- 2SEC: 13F for the quarter ended June 30, 2026https://www.sec.gov/Archives/edgar/data/1937964/000193796426000008/Filed August 14, 2026 · accession 0001937964-26-000008